Category: IBC

Join us for an insightful presentation on research protection and ethical collaboration. American universities lead the way in cutting-edge research, but when this research is exploited by individuals with nefarious intentions, it can have serious consequences—tarnishing reputations, leading to funding losses, lab closures, and legal issues.

This session, presented by the FBI, will focus on: Steps to secure intellectual property and research materials and proper practices for collaborating with international universities.

DATE: March 6, 2025

TIME: 12:00 pm

PRESENTER: Nathan Livesey, FBI-WMD Coordinator

Location: G100 BRC (IN-PERSON ONLY)

The narrow federal definition of Research Misconduct–Fabrication/Falsification/Plagiarism–does not account for all sorts of other bad practices, including unprofessional conduct, which can include but is not limited to harassment, bullying, etc. This presentation will include how professional misconduct is defined, how these behaviors impact research integrity, how to prevent and report misconduct in all forms, and the potential outcomes.

Presenter: Robin Tyndall, Director of the Office of Research Compliance

When: February 20, 2025 from 12 PM – 1 PM

Location: Via Zoom Meeting ID: 965 2454 6984 I Passcode: 084850

We hope you’ve been finding our newsletter informative and engaging! If you’ve missed any past editions or want to revisit important updates, we’ve got you covered. You can now access past newsletters on our website—just head to the Resource tab and click on Newsletter.

Check them out and stay informed!

Join us for an engaging seminar by Dr. Holden Thorp, George Washington University and Editor-in-chief at Science, as he discusses the critical role of graduate education in advancing science and society.

Hosted By: The Chemistry Department

When: February 6^th at 4:15 PM — Hendrix Student Center; McKissick Theatre

Details Here

Hello! The Office of Research Compliance (ORC) has a new Newsletter!

Stay informed with the latest updates and essential information on IACUC, IRB, IBC, and RCR. Subscribe to be your go-to resource for policies, procedures, and best practices in research compliance.

Please click the link to sign up!

This policy establishes requirements for transporting hazardous materials between University facilities for University-related business and to promote safe practices while reducing liability risks for University personnel and the community, adhering to federal and state regulations.

• Transportation of Hazardous Materials Policy
• Clemson News – New Transportation of Hazardous Materials policy approved

The White House announced the release of a revised policy on the oversight of dual-use research of concern (DURC) and pathogens with enhanced pandemic potential (PEPPs). Some of the new elements include: defined roles, clear levels of oversight, and new list of pathogens covered. The new policy can be found here: https://www.whitehouse.gov/wp-content/uploads/2024/05/USG-Policy-for-Oversight-of-DURC-and-PEPP.pdf

This spring ORC engaged external consultants to review the IRB and IACUC office operations. Since then, we have been busy implementing their recommendations. In the fall, we look forward to unveiling updated eForms in InfoEd, new positions, new staff, updated guidance and “how to’s” and a new communications strategy. If you would like an update on our progress at a staff or department meeting, please contact us at orc@clemson.edu. Stay tuned!

The Division of Research keeps a list of Regulatory Alerts that impact Sponsored Programs, Research Security, Post-Award and Compliance. We provide timely updates regarding regulatory and policy changes that can impact your proposals and conduct of research. Be sure to check out the Regulatory Alerts page periodically for new updates.

The NIH has published revisions to the NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules (NIH Guidelines). These revisions are specific for research involving gene drive modified organisms (GDMOs) in research settings. These revisions include:

• Research with GDMOs requires IBC review and approval PRIOR to initiation.
• The minimum containment level for research involving GDMOs will be BSL-2.
• When a researcher at an institution conducts research involving GDMOs, the institution must ensure that the IBC has adequate expertise on the committee as well as a BSO (biosafety officer).

Clemson’s Office or Research Compliance will be updating the e-form in InfoEd to reflect the category for this research (III-D-8).